Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis

Tan, Kathrine R.; Magill, Alan J.; Parise, Monica E.; Arguin, Paul M.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis

Published Date:

Apr 2011

Source:

Am J Trop Med Hyg. 2011; 84(4):517-531.

Language:

English

[PDF-506.19 KB]

Details:

Alternative Title:

Am J Trop Med Hyg

Personal Author:

Tan, Kathrine R. ; Magill, Alan J. ; Parise, Monica E. ; Arguin, Paul M. ;

Description:

Doxycycline, a synthetically derived tetracycline, is a partially efficacious causal prophylactic (liver stage of Plasmodium) drug and a slow acting blood schizontocidal agent highly effective for the prevention of malaria. When used in conjunction with a fast acting schizontocidal agent, it is also highly effective for malaria treatment. Doxycycline is especially useful as a prophylaxis in areas with chloroquine and multidrug-resistant Plasmodium falciparum malaria. Although not recommended for pregnant women and children < 8 years of age, severe adverse events are rarely reported for doxycycline. This report examines the evidence behind current recommendations for the use of doxycycline for malaria and summarizes the available literature on its safety and tolerability.

Subject:

[+]

Document Type:

Journal Article

Place as Subject:

United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	license.txt	text/plain
	tropmed-84-517.nxml	text/plain

No Related Documents.

You May Also Like:

Record of the proceedings; Department of Health and Human Services and Centers for Disease Control and Prevention convene the Expert Meeting on Malaria Chemoprophylaxis, Atlanta, Georgia, January 29-30, 2003

Corporate Authors:

Centers for Disease Control and Prevention (U.S). National Center for Infectious Diseases (U.S.). United States, Dept. of Health and Human Services.

Conference Authors:

Expert Meeting on Malaria Chemoprophylaxis (2003 : Atlanta, GA)

Published Date:

2006

Description:

The Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (DHHS) convened an Expert Meeting on Malaria Chemoprophylaxis. The proceedings were held at the DoubleTree Hotel in Atlanta, Georgia on January 29-30,...

File Type:

[PDF - 218.12 KB]
Economics of Malaria Prevention in US Travelers to West Africa

Personal Author:

Adachi, Kenji; Coleman, Margaret S.; Khan, Nomana; Jentes, Emily S.; Arguin, Paul; Rao, Sowmya R.; LaRocque, Regina C.; Sotir, Mark J.; Brunette, Gary; Ryan, Edward T.; Meltzer, Martin I.;

Corporate Authors:

The Global TravEpiNet Consortium

Published Date:

Sep 06 2013

Source:

Clin Infect Dis. 2013; 58(1):11-21.

Description:

Pretravel health consultations help international travelers manage travel-related illness risks through education, vaccination, and medication. This study evaluated costs and benefits of that portion of the health consultation associated with malaria...

File Type:

[PDF - 504.37 KB]
A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy

Personal Author:

Tan, Kathrine R.; Fairley, Jessica K.; Wang, Mengxi; Gutman, Julie R.;

Published Date:

May 15 2018

Source:

Malar J. 17.

Description:

BackgroundMalaria chemoprophylaxis options in pregnancy are limited, and atovaquone–proguanil (AP) is not recommended because of insufficient safety evidence. An anonymous, internet-based survey was disseminated to describe outcomes of pregnancies ...

File Type:

[PDF - 827.64 KB]
Malaria Surveillance--United States, 2016

Personal Author:

Mace, Kimberly E.; Arguin, Paul M.; Lucchi, Naomi W.; Tan, Kathrine R.;

Corporate Authors:

Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria. Malaria Branch.

Published Date:

May 17, 2019

Source:

MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries

Series:

MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; v. 68, no. SS-5

Description:

Problem/Condition: Malaria in humans is caused by intraerythrocytic protozoa of the genus Plasmodium. These parasites are transmitted by the bite of an infective female Anopheles species mosquito. The majority of malaria infections in the United Stat...

File Type:

[PDF - 937.81 KB]
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019

Personal Author:

Haston, Julia C.; Hwang, Jimee; Tan, Kathrine R.;

Corporate Authors:

Emory University School of Medicine. Department of Pediatrics.. Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.. President's Malaria Initiative (U.S.).

Published Date:

November 22 2019

Source:

MMWR Morb Mortal Wkly Rep. 68(46):1062-1068

Description:

An estimated 219 million cases of malaria occurred worldwide in 2017, causing approximately 435,000 deaths (1). Malaria is caused by intraerythrocytic protozoa of the genus Plasmodium transmitted to humans through the bite of an infective Anopheles m...

File Type:

[PDF - 464.45 KB]